Absence of beta3 integrin accelerates early skeletal repair

Journal of Orthopaedic Research

Volumn 28, Issue 1, 2010, Pages 32-37

  Hu, Diane ^a   Lu, Chuanyong ^a   Sapozhnikova, Anna ^a   Barnett, Michael ^a   Sparrey, Carolyn ^a   Miclau, Theodore ^a   Marcucio, Ralph S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Beta3 integrin; Endochondral ossification; Fracture repair cartilage

Indexed keywords

BETA3 INTEGRIN; HEMOGLOBIN;

ANEMIA; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BLEEDING TIME; BLOOD CELL COUNT; BLOOD VESSEL; CALLUS; CARTILAGE; CONTROLLED STUDY; FRACTURE HEALING; GENE OVEREXPRESSION; MALE; MATURATION; MORPHOMETRICS; MOUSE; MUTANT; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PROTEIN FUNCTION; WILD TYPE;

ANIMALS; BIOMECHANICS; BONY CALLUS; CARTILAGE; DISEASE MODELS, ANIMAL; FRACTURE HEALING; INTEGRIN BETA3; MALE; MICE; MICE, KNOCKOUT; TIBIA; TIBIAL FRACTURES;

EID: 73249150935     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20955     Document Type: Article

References (27)

1. Takada Y, Ye X, Simon S. 2007. The integrins. Genome Biol 8:215-224.
2. Quinn MJ, Byzova TV, Qin J, et al. 2003. Integrin alphaIIbbeta3 and its antagonism. Arterioscler Thromb Vasc Biol 23:945-952.
3. Zhao H, Kitaura H, Sands MS, et al. 2005. Critical role of beta3 integrin in experimental postmenopausal osteoporosis. J Bone Miner Res 20:2116-2123.
4. Brooks PC, Clark RA, Cheresh DA. 1994. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264:569-571.
5. McHugh KP, Hodivala-Dilke K, Zheng M-H, et al. 2000. Mice lacking {beta}3 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest 105:433-440.
6. Faccio R, Takeshita S, Zallone A, et al. 2003. c-Fms and the alphavbeta3 integrin collaborate during osteoclast differentiation. J Clin Invest 111:749-758.
7. Reynolds LE, Wyder L, Lively JC, et al. 2002. Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nat Med 8:27-34.
8. Lu C, Miclau T, Hu D, et al. 2007. Ischemia leads to delayed union during fracture healing: a mouse model. J Orthop Res 25:51-61.
9. Hodivala-Dilke KM, McHugh KP, Tsakiris DA, et al. 1999. Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest 103:229-238.
10. Lu C, Miclau T, Hu D, et al. 2005. Cellular basis for agerelated changes in fracture repair. J Orthop Res 23:1300-1307.
11. Lu C, Marcucio R, Miclau T. 2006. Assessing angiogenesis during fracture healing. Iowa Orthop J 26:17-26.
12. Lu C, Hansen E, Sapozhnikova A, et al. 2008. Effect of age on vascularization during fracture repair. J Orthop Res 26:1384-1389.
13. Gundersen HJ, Jensen EB. 1987. The efficiency of systematic sampling in stereology and its prediction. J Microsc 147:229-263.
14. Hauser CJ, Joshi P, Zhou X, et al. 1996. Production of interleukin-10 in human fracture soft-tissue hematomas. Shock 6:3-6.
15. Street J, Winter D, Wang JH, et al. 2000. Is human fracture hematoma inherently angiogenic? Clin Orthop Relat Res 373:224-237.
16. Timlin M, Toomey D, Condron C, et al. 2005. Fracture hematoma is a potent proinflammatory mediator of neutrophil function. J Trauma 58:1223-1229.
17. Grundnes O, Reikeras O. 1993. The importance of the hematoma for fracture healing in rats. Acta Orthop Scand 64:340-342.
18. Street JT, McGrath M, O′Regan K, et al. 2000. Thromboprophylaxis using a low molecular weight heparin delays fracture repair. Clin Orthop Relat Res 381:278-289.
19. Hak DJ, Stewart RL, Hazelwood SJ. 2006. Effect of low molecular weight heparin on fracture healing in a stabilized rat femur fracture model. J Orthop Res 24:645-652.
20. Hirsh J, Warkentin TE, Shaughnessy SG, et al. 2001. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 119:64S-94S.
21. Wagner DD, Burger PC. 2003. Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol 23:2131-2137.
22. Gandhi A, Doumas C, O′Connor JP, et al. 2006. The effects of local platelet rich plasma delivery on diabetic fracture healing. Bone 38:540-546.
23. Brooks PC, Stromblad S, Klemke R, et al. 1995. Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest 96:1815-1822.
24. Brooks PC, Montgomery AM, Rosenfeld M, et al. 1994. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79:1157-1164.
25. Taverna D, Moher H, Crowley D, et al. 2004. Increased primary tumor growth in mice null for beta3- or beta3/ beta5-integrins or selectins. Proc Natl Acad Sci USA 101:763-768.
26. Reynolds AR, Reynolds LE, Nagel TE, et al. 2004. Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in beta3-integrin-deficient mice. Cancer Res 64:8643-8650.
27. Schell H, Lienau J, Epari DR, et al. 2006. Osteoclastic activity begins early and increases over the course of bone healing. Bone 38:547-554.